Scientists have solved the mystery behind how Candida auris produces more drug-resistant, virulent strains of itself.
Two nuclear experts discussed small modular reactor research and development in Canada at the Standing Committee on Science and Research.
A five-year partnership between McMaster, Mitacs and Canadian biotech company Fusion Pharmaceuticals has created a unique training ground for graduate students pursuing leading-edge experience using radiopharmaceuticals for cancer detection and treatment.